tobramycin has been researched along with Deafness, Transitory in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (33.33) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Čusak, A; Durán-Alonso, MB; Fernández-Martínez, M; Fujs, Š; García-Mateo, N; Ishikawa, M; Knipper, M; Kosec, G; López-Hernández, I; Löwenheim, H; Martínez-Martínez, L; Müller, M; Petković, H; Rüttiger, L; Schimmang, T; Singer, W | 1 |
| Baladi, B; Calmels, MN; Concordet, D; Gallois, Y; Gandia, P; Madaule, J; Mittaine, M; Murris, M; Valenzuela, F | 1 |
| Carroll, WD; Ditchfield, N; Gilchrist, FJ | 1 |
| Burt, RA; Lockhart, PJ; Ogier, JM | 1 |
| Gu, R; Homan, J; Kil, J; Longenecker, RJ | 1 |
| Garinis, A; Gleser, M; Johns, A; Larsen, E; Vachhani, J | 1 |
| Dorgan, D; Fifer, RC; Flume, PA; Harruff, EE; Jain, R; Kil, J; Kim, YJM; Ortiz, MGT; Poth, EA; Shoup, AG | 1 |
| Paterson, S | 1 |
| Carroll, K; Cohen, DM; Cross, CP; Feeney, MP; Garinis, AC; Gold, JA; Hunter, LL; Keefe, DH; Putterman, DB; Srikanth, P; Steyger, PS | 1 |
| Boni, V; Braccini, G; Braggion, C; Ciuti, R; De Martino, M; Festini, F; Lori, I; Neri, AS; Pela, I; Taccetti, G; Zavataro, L | 1 |
| de Hoog, M; Hop, WC; Overbosch, E; van den Anker, JN; van Zanten, BA; Weisglas-Kuperus, N | 1 |
| Hyman-Taylor, P; Knox, A; Lewis, S; Mulheran, M; Smyth, A; Stableforth, D; Tan, KH | 1 |
| Lerner, AM; Reyes, MP; Rintelmann, WF; Tablan, OC | 1 |
| Lietman, PS; Moore, RD; Smith, CR | 1 |
| Antonelli, M; Crifo, S; Gagliardi, M; Lucarelli, N; Marcolini, P | 1 |
| Arnesen, AR; Bruun, JN; Eng, J | 1 |
| Hermenegildo, M; Poveda, JL; Querol, JM; Quintana, MB; Rocher, A; Sánchez-Alcaraz, A; Vargas, A | 1 |
| Abramson, AL; Forman-Franco, B; Gorvoy, JD; Stein, T | 1 |
| Fausti, SA; Frey, RH; Henry, JA; McDonald, WJ; Olson, DJ; Schaffer, HI | 1 |
| Voogt, GR | 1 |
| Bernstein, JM; Brummett, RE; Gorse, GJ; Levin, RD; Linzmayer, MI; Lorber, RR; Markowitz, N; Pegram, PS; Saravolatz, LD | 1 |
4 trial(s) available for tobramycin and Deafness, Transitory
| Article | Year |
|---|---|
Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Audiometry, Pure-Tone; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Hearing Loss; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2006 |
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
Topics: Amikacin; Body Temperature; Female; Gentamicins; Hearing Loss; Humans; Kanamycin; Male; Probability; Risk; Sepsis; Statistics as Topic; Time Factors; Tobramycin | 1984 |
Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Creatinine; Drug Administration Schedule; Drug Monitoring; Female; Hearing Loss; Humans; Kidney; Male; Middle Aged; Tobramycin | 1998 |
Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients.
Topics: Adult; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Hearing Loss; Humans; Immune Tolerance; Infections; Middle Aged; Neoplasms; Netilmicin; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1986 |
17 other study(ies) available for tobramycin and Deafness, Transitory
| Article | Year |
|---|---|
Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cell Line; Drug Resistance, Bacterial; Gentamicins; Guinea Pigs; Hair Cells, Auditory, Inner; Hearing Loss; Humans; Nebramycin; Neomycin; Ototoxicity; Protein Synthesis Inhibitors; Round Window, Ear | 2019 |
Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Cystic Fibrosis; Hearing Loss; Humans; Ototoxicity; Retrospective Studies; Tobramycin | 2023 |
Unwarranted use of intravenous aminoglycosides at UK paediatric cystic fibrosis centres.
Topics: Administration, Intravenous; Aminoglycosides; Anti-Bacterial Agents; Child; Cystic Fibrosis; Health Care Surveys; Hearing Loss; Humans; Inappropriate Prescribing; Kidney Diseases; Pediatrics; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; United Kingdom | 2019 |
Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Hearing; Hearing Loss; Injections, Intravenous; Kidney; Kidney Diseases; Mice, Inbred C57BL; Ototoxicity; Species Specificity; Time Factors; Tobramycin | 2020 |
Ebselen attenuates tobramycin-induced ototoxicity in mice.
Topics: Animals; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory, Outer; Hearing Loss; Isoindoles; Mice; Organoselenium Compounds; Ototoxicity; Tobramycin | 2021 |
Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin.
Topics: Administration, Intravenous; Adolescent; Adult; Aminoglycosides; Audiometry, Pure-Tone; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Ototoxicity; Prospective Studies; Tobramycin | 2021 |
Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.
Topics: Administration, Intravenous; Adolescent; Adult; Aminoglycosides; Audiometry, Pure-Tone; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Ototoxicity; Respiratory Tract Infections; Symptom Flare Up; Tobramycin | 2021 |
Brainstem auditory evoked responses in 37 dogs with otitis media before and after topical therapy.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Dogs; Ear, Middle; Evoked Potentials, Auditory, Brain Stem; Fluoroquinolones; Gentamicins; Hearing Loss; Otitis Media; Ticarcillin; Tobramycin | 2018 |
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Amikacin; Anti-Bacterial Agents; Audiometry, Pure-Tone; Bacterial Infections; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Outcome Assessment; Sex Factors; Time; Tobramycin; United States; Vancomycin | 2017 |
Parenteral administration of tobramycin for pulmonary exacerbations in cystic fibrosis patients: toxicity, serum levels and efficacy.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Cochlea; Cystic Fibrosis; Female; Gram-Negative Bacterial Infections; Hearing Loss; Humans; Infusions, Parenteral; Kidney; Male; Tobramycin | 2009 |
Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss.
Topics: Anti-Bacterial Agents; Audiometry; Dose-Response Relationship, Drug; Drug Administration Schedule; Evoked Potentials, Auditory, Brain Stem; Hearing Loss; Humans; Infant, Newborn; Neonatal Screening; Risk Factors; Tobramycin; Vancomycin | 2003 |
Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.
Topics: Adult; Auditory Threshold; Creatinine; Endocarditis, Bacterial; Female; Gentamicins; Hearing Loss; Hearing Loss, Bilateral; Humans; Kidney Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1984 |
Ototoxicity of aminoglucoside antibiotics in long-term treatment for cystic fibrosis.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Gentamicins; Hearing Loss; Hearing Loss, Conductive; Hearing Loss, Sensorineural; Humans; Long-Term Care; Tobramycin | 1980 |
Tobramycin therapy of serious infections. Pharmacological aspects and side effects.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Hearing Loss; Humans; Kidney Function Tests; Middle Aged; Tobramycin; Vestibular Function Tests | 1981 |
Cystic fibrosis and hearing loss.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Audiometry; Auditory Threshold; Child; Cystic Fibrosis; Ear Ossicles; Ear, Middle; Female; Gentamicins; Hearing Loss; Hearing Loss, Conductive; Hearing Loss, Sensorineural; Humans; Male; Pressure; Stapes; Tobramycin; Tympanic Membrane | 1979 |
High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.
Topics: Amikacin; Anti-Bacterial Agents; Audiometry; Gentamicins; Hearing Loss; Hearing Loss, Bilateral; Hearing Loss, High-Frequency; Humans; Male; Middle Aged; Prospective Studies; Tobramycin | 1992 |
Early detection of ototoxicity by high-frequency audiometry--a case study.
Topics: Adult; Audiometry; Female; Hearing Loss; Hearing Loss, High-Frequency; Humans; Time Factors; Tobramycin | 1987 |